diabetestalk.net

Treating Diabetes With Cannabis?

Treating Diabetes with Cannabis?

Treating Diabetes with Cannabis?

I am still grinning. Can you see me? Over 10 years back in 2005, we published a brief post here at the ‘Mine about how cannabis (yep: pot, grass, weed, ganja...) can be used to treat diabetes. Really, completely legit! And people have been flocking here ever since to learn more.
Now, at the kickoff of 2016, we’re updating that post with a bunch more detail. Seriously, there is a growing body of research (OK, much of it in animals) showing that cannabis can have a number of positive effects on diabetes.
It begins with that original 2005 research paper that we highlighted from the American Alliance for Medical Cannabis (AAMC), which purported that cannabis can have the following benefits for PWDs (people with diabetes):
stabilizing blood sugars (confirmed via "a large body of anecdotal evidence building among diabetes sufferers")
anti-inflammatory action that may help quell some of the arterial inflammation common in diabetes
"neuroprotective" effects that help thwart inflammation of nerves and reduce the pain of neuropathy by activating receptors in the body and brain
"anti-spasmodic agents" help relieve muscle cramps and the pain of gastrointestinal (GI) disorders
acts as a "vasodilator" to help keep blood vessels open and improve circulation
contributes to lower blood pressure over time, which is vital for diabetics
substituting cannabis butter and oil in foods "benefits cardiac and arterial health in general"
it can also be used to make topical creams to relieve neuropathic pain and tingling in hands and feet
helps calm diabetic "restless leg syndrome" (RLS), so the p Continue reading

Rate this article
Total 1 ratings
ACTION CENTER

ACTION CENTER

Nearly 30 million Americans live with diabetes; 86 million more have prediabetes and the epidemic keeps growing. Someone in the United States is diagnosed with diabetes every 23 seconds. And with every diagnosis, another American faces terrible life-threatening complications.
We can't wait. Join with us in asking Congress to stand up to diabetes.
Congress: Do your part to Stop Diabetes®:
Increase funding for the National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the main federal agency that conducts research to find a cure and advance treatments for all types of diabetes. This investment in NIDDK is needed to prevent diabetes, improve care to prevent the devastating complications of diabetes, and – ultimately find a cure.
Fully support the Centers for Disease Control and Prevention’s Division of Diabetes Translation (DDT) in its crucial efforts to lessen the burden diabetes has on American families through education, understanding how diabetes impacts communities, and by translating science into real-world help.
Provide more resources for the National Diabetes Prevention Program (National DPP) a public-private partnership providing cost-effective, highly successful diabetes prevention programs for those at high risk for type 2 diabetes. Brought to scale, this program can dramatically reduce the number of new diabetes cases among the 86 million Americans with prediabetes. Continue reading

FDA approves first ‘artificial pancreas’ for diabetes treatment

FDA approves first ‘artificial pancreas’ for diabetes treatment

The Food and Drug Administration on Wednesday approved the first so-called artificial pancreas, an out-of-body device expected to lift the burden for some diabetics on the daily grind they must go through to keep their blood sugar levels stable. It will be available next spring for patients with type 1 diabetes who are over age 14.
The device, which looks like a smartphone, is designed to automatically monitor and administer the delivery of insulin for type 1 diabetes patients, whose ability to provide insulin naturally is impaired. It wirelessly links up an insulin pump and glucose monitor, allowing patients to partly turn over the process of testing and adjusting their blood sugar levels. It’s not unlike cruise control: Patients still have to manually control their glucose levels before they eat.
In the diabetes community, optimism about the new device is tempered by fears that it will command a high price tag that could put it out of reach for patients already grappling with the soaring cost of insulin. Medtronic, which developed the “MiniMed 670G,” has yet to announce how much it plans to charge. But spokeswoman Leslie Bryant said the company expects to offer it “at currently offered Medtronic pump system pricing” and is talking with health plans to “enable patient access.”
Medtronic’s application was approved on the back of a study that tested how 123 type 1 diabetes patients fared on the device. No patients reported developing complications like excess blood acids or low glucose levels that can result from poor monitoring of the disease.
Medtronic is a Continue reading

A Vaccine For Type 1 Diabetes Begins Human Trials in 2018

A Vaccine For Type 1 Diabetes Begins Human Trials in 2018

A prototype vaccine, decades in the making, that could prevent type 1 diabetes in children is ready to start clinical trials in 2018.
It's not a cure, and it won't eliminate the disease altogether, but the vaccine is expected to provide immunity against a virus that has been found to trigger the body's defences into attacking itself, potentially reducing the number of new diabetes cases each year.
Over two decades of research led by the University of Tampere in Finland has already provided solid evidence linking a type of virus called coxsackievirus B1 with an autoimmune reaction that causes the body to destroy cells in its own pancreas.
The type 1 form of diabetes – not to be confused with the more prevalent type 2 variety that tends to affect individuals later in life – is a decreased ability to produce the insulin used by the body's cells to absorb glucose out of the blood.
This loss of insulin is the result of pancreatic tissue called beta cells being destroyed by the body's own immune system, often within the first few years of life.
It's something of a mystery as to why the body identifies beta cells as foreign, though there could be a genetic link producing variations of human leukocyte markers, which act as the cell's 'ID tags'.
No doubt it's complex, and there are numerous ways this process can be triggered. One example established by virologist Heikki Hyöty from the University of Tampere is an infection by a type of enterovirus.
Enteroviruses are nasty pieces of work; you might be most familiar with polio, but they can also cause hand, foot and mouth disease, Continue reading

CMAJ article links hunger in residential schools to Type 2 diabetes, obesity

CMAJ article links hunger in residential schools to Type 2 diabetes, obesity

Widespread, prolonged hunger that existed in residential schools is a contributing factor in the disproportionate health issues facing many Indigenous people, such as diabetes and obesity, according to an article published Monday in the Canadian Medical Association Journal.
"Hunger is really central to the experiences of residential school survivors," says Ian Mosby who co-authored the article with Tracy Galloway, both with the University of Toronto.
They say childhood malnutrition experienced in many government-funded schools is contributing to the higher risk for obesity, diabetes and heart disease among Indigenous people in adulthood.
"While this wasn't every single residential school," says Mosby, "it's common enough through survivor testimony that we need to start looking at hunger in residential schools as a real predictor of long-term health problems."
Residential schools across Canada faced significant underfunding, along with inadequate cooking facilities and untrained staff. Historians and former students have described children getting "one or two pieces of stale bread for lunch. Rarely getting meat, rarely getting milk and butter, and few fruits and vegetables," says Mosby.
He estimates many students received 1,000 to 1,400 calories a day. A normal range for a child's healthy development is 1,400 to 3,200.
Famine studies in China, Russia and the Netherlands show height-stunted youth developed greater insulin sensitivity and lower insulin levels, making them prone to developing Type 2 diabetes, the article notes.
That, paired with hormone changes from lack of foo Continue reading

No more pages to load

Popular Articles

Related Articles